Evidence map›Paper›PMID 38504018›Full record

ArticleNature medicine2024

Towards a general-purpose foundation model for computational pathology.

Richard J Chen, Tong Ding, Ming Y Lu, Drew F K Williamson, Guillaume Jaume, Andrew H Song, Bowen Chen, Andrew Zhang, Daniel Shao, Muhammad Shaban and 10 more

Abstract read
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 642 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
642citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

642 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
    Article
  18. Article
  19. Article
  20. Article

582 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Richard J Chen *Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-0389-1331
Tong Ding *Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Ming Y Lu *Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Drew F K Williamson *Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1745-8846
Guillaume JaumeDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Andrew H SongDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Bowen ChenDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Andrew ZhangDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-9432-2793
Daniel ShaoDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Muhammad ShabanDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Mane WilliamsDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Lukas OldenburgDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Luca L WeishauptDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Judy J WangDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Anurag VaidyaDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Long Phi LeDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Georg GerberDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-9149-5509
Sharifa SahaiDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Walt WilliamsDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Faisal MahmoodDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. faisalmahmood@bwh.harvard.edu.ORCID 0000-0001-7587-1562

Funding

Training Program in Bioinformatics and Integrative GenomicsT32HG002295 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Peter J Park · 2001 to 2026
$15.8M
Oncopathology Training ProgramT32CA251062 · NCI · DANA-FARBER CANCER INST · PI JON C. ASTER, KATHLEEN H BURNS · 2020 to 2026
$2.4M
Probabilistic deep learning models and integrated biological experiments for analyzing dynamic and heterogeneous microbiomesR35GM149270 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Georg Kurt Gerber · 2023 to 2026
$1.8M
NCI NIH HHS T32 CA251062NHGRI NIH HHS T32 HG002295NIGMS NIH HHS R35 GM149270
6 · The paper itself

Abstract

Quantitative evaluation of tissue images is crucial for computational pathology (CPath) tasks, requiring the objective characterization of histopathological entities from whole-slide images (WSIs). The high resolution of WSIs and the variability of morphological features present significant challenges, complicating the large-scale annotation of data for high-performance applications. To address this challenge, current efforts have proposed the use of pretrained image encoders through transfer learning from natural image datasets or self-supervised learning on publicly available histopathology datasets, but have not been extensively developed and evaluated across diverse tissue types at scale. We introduce UNI, a general-purpose self-supervised model for pathology, pretrained using more than 100 million images from over 100,000 diagnostic H&E-stained WSIs (>77 TB of data) across 20 major tissue types. The model was evaluated on 34 representative CPath tasks of varying diagnostic difficulty. In addition to outperforming previous state-of-the-art models, we demonstrate new modeling capabilities in CPath such as resolution-agnostic tissue classification, slide classification using few-shot class prototypes, and disease subtyping generalization in classifying up to 108 cancer types in the OncoTree classification system. UNI advances unsupervised representation learning at scale in CPath in terms of both pretraining data and downstream evaluation, enabling data-efficient artificial intelligence models that can generalize and transfer to a wide range of diagnostically challenging tasks and clinical workflows in anatomic pathology.

Indexed as

Artificial IntelligenceWorkflow

Identifiers

PMID38504018
PMCPMC11403354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.